Cargando…

Diagnosis of Hypersensitivity Induced by Antituberculosis Drugs

OBJECTIVE: To explore the clinical value of the specific plasma cell detection and specific T lymphocyte detection test in diagnosing hypersensitivity caused by antituberculosis drugs. METHODS: A total of 266 patients with pulmonary tuberculosis who developed hypersensitivity during the treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yuqing, Xiao, Guangming, Zong, Peilan, Jiang, Guoqiang, Liao, Yongmei, Liu, Zhou, Zhou, Yanhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712148/ https://www.ncbi.nlm.nih.gov/pubmed/34875682 http://dx.doi.org/10.1155/2021/6455659

Ejemplares similares

Management of type 1 immediate hypersensitivity reactions to antituberculosis drug: succesful desensitization
por: Katran, Zeynep Yegin, et al.
Publicado: (2022)

P25 - Hypersensitivity/adverse reactions to antituberculosis drugs – a case report
por: Barrosa Maia, Estefânia, et al.
Publicado: (2014)

Antituberculosis Drug‐Induced Adverse Events in the Liver, Kidneys, and Blood: Clinical Profiles and Pharmacogenetic Predictors
por: Hu, Xuejiao, et al.
Publicado: (2017)

Antituberculosis drug-induced hepatotoxicity in children
por: Donald, Peter R
Publicado: (2011)

Acquired Resistance to Antituberculosis Drugs
por: Aung, Htin Lin, et al.
Publicado: (2018)

Association of PXR and CAR Polymorphisms and Antituberculosis Drug-Induced Hepatotoxicity
por: Wang, Yu, et al.
Publicado: (2019)

Genetic and Functional Evaluation of the Role of FOXO1 in Antituberculosis Drug-Induced Hepatotoxicity
por: Zhang, Jingwei, et al.
Publicado: (2021)

Antituberculosis Drug-Induced Fixed Drug Eruption: A Case Report
por: Vaghela, Jitendra H., et al.
Publicado: (2018)

The Variant at TGFBRAP1 but Not TGFBR2 Is Associated with Antituberculosis Drug-Induced Liver Injury
por: Zhang, Jingwei, et al.
Publicado: (2019)

Antituberculosis Drugs (Rifampicin and Isoniazid) Induce Liver Injury by Regulating NLRP3 Inflammasomes
por: Su, Qiang, et al.
Publicado: (2021)

Epidemiology of tuberculosis and susceptibility to antituberculosis drugs in Reunion Island
por: Loukman, Moreea, et al.
Publicado: (2023)

Mycobacterium tuberculosis resistance to antituberculosis drugs in Mozambique,
por: Pires, Germano Manuel, et al.
Publicado: (2014)

ABCC2 Haplotype is Associated With Antituberculosis Drug-Induced Maculopapular Eruption
por: Kim, Sang-Heon, et al.
Publicado: (2012)

Naringenin mitigates antituberculosis drugs induced hepatic and renal injury in rats
por: Sahu, Nisha, et al.
Publicado: (2019)

Adverse Reactions to Antituberculosis Drugs in Iranian Tuberculosis Patients
por: Farazi, Aliasghar, et al.
Publicado: (2014)

Risk factors associated with adverse reactions to antituberculosis drugs
por: Resende, Laíse Soares Oliveira, et al.
Publicado: (2015)

Seizures following Intoxication with a Common Antituberculosis Drug
por: Lahlou, Adnane, et al.
Publicado: (2019)

Aureolic Acid Group of Agents as Potential Antituberculosis Drugs
por: Bespyatykh, Julia, et al.
Publicado: (2020)

Impact of Non-Alcoholic Simple Fatty Liver Disease on Antituberculosis Drug-Induced Liver Injury
por: Liu, Yi-Hui, et al.
Publicado: (2021)

Unusual Recurrence of Antituberculosis Drug-Induced Hepatotoxicity in Children: A Case Series
por: Nataprawira, Heda Melinda, et al.
Publicado: (2021)

Genetic polymorphisms of N-acetyltransferase 2 & susceptibility to antituberculosis drug-induced hepatotoxicity
por: Sharma, Surendra K., et al.
Publicado: (2016)

Safety Evaluation of Antituberculosis Drugs During Pregnancy: A Systematic Review and Meta-Analysis
por: Zhou, Xiaomei, et al.
Publicado: (2022)

Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence
por: Andreu, Nuria, et al.
Publicado: (2012)

Antituberculosis Drug Resistance Survey in Lesotho, 2008-2009: Lessons Learned
por: Maama-Maime, Llang B., et al.
Publicado: (2015)

New Antituberculosis Drugs: From Clinical Trial to Programmatic Use
por: Gualano, Gina, et al.
Publicado: (2016)

Adverse drug reaction profile of daily regimen antituberculosis treatment
por: Sankar, K. N. Hari, et al.
Publicado: (2022)

Clinical impact of plasma concentrations of first-line antituberculosis drugs
por: Perumal, R, et al.
Publicado: (2023)

Antituberculosis Drug-Induced Hepatotoxicity in IranianTuberculosis Patients: Role of Isoniazid Metabolic Polymorphism
por: Sistanizad, Mohammad, et al.
Publicado: (2011)

Associations of GCLM, gclc and GSTP1 gene polymorphisms and antituberculosis drugs-induced hepatitis
por: Kim, Sang-Heon, et al.
Publicado: (2015)

Antituberculosis Drug-Induced Liver Injury with Autoimmune Features: Facing Diagnostic and Treatment Challenges
por: Rangel, Maria Adriana, et al.
Publicado: (2017)

The "nocebo effect" in drug hypersensitivity diagnosis
por: Bommarito, Luisa, et al.
Publicado: (2014)

A Semimechanistic Pharmacokinetic Model for Depot Medroxyprogesterone Acetate and Drug–Drug Interactions With Antiretroviral and Antituberculosis Treatment
por: Francis, Jose, et al.
Publicado: (2021)

Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis
por: Kart, Levent, et al.
Publicado: (2002)

Acquired Resistance to Antituberculosis Drugs in England, Wales, and Northern Ireland, 2000–2015
por: Loutet, Miranda G., et al.
Publicado: (2018)

A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury
por: Luangchosiri, Chote, et al.
Publicado: (2015)

Amelioration of Nephrotoxicity in Mice Induced by Antituberculosis Drugs Using Ensete ventricosum (Welw.) Cheesman Corm Extract
por: Dubiwak, Abebe Dukessa, et al.
Publicado: (2022)

Incidence and Temporal Trend of Antituberculosis Drug-Induced Liver Injury: A Systematic Review and Meta-Analysis
por: Wang, Nannan, et al.
Publicado: (2022)

Effective Interventions and Decline of Antituberculosis Drug Resistance in Eastern Taiwan, 2004–2008
por: Chen, Yi-Ting, et al.
Publicado: (2012)

The Antituberculosis Drug Ethambutol Selectively Blocks Apical Growth in CMN Group Bacteria
por: Schubert, Karin, et al.
Publicado: (2017)

Liver Transplantation in Antituberculosis Drugs-Induced Fulminant Hepatic Failure: A Case Report and Review of the Literature
por: Li, Xiaoyan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_83qvgharmoptcnqtmbemv41ki1